Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still’s disease
Adult-onset Still's disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high risk for macrophage activation syndrome (MAS). MAS development is associated with monocyte/macrophage activation and cytokine storm. Monocytes consist of three...
Saved in:
| Published in | BMC medicine Vol. 21; no. 1; pp. 507 - 15 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
20.12.2023
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Adult-onset Still's disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high risk for macrophage activation syndrome (MAS). MAS development is associated with monocyte/macrophage activation and cytokine storm. Monocytes consist of three different subsets, classical monocytes (CMs, CD14
CD16 -), intermediate monocytes (IMs, CD14
CD16 +), and non-classical monocytes (NCMs, CD14
CD16 +), each has distinct roles in inflammatory regulation. However, the frequencies and regulatory mechanism of monocyte subsets in AOSD patients have not been identified.
We performed flow cytometry, RNA sequencing, phagocytosis analysis, and enzyme-linked immunosorbent assay to evaluate monocyte subsets, cell functions, and potential biomarkers. The effect of neutrophil extracellular traps (NETs) on monocytes was determined by evaluating mRNA levels of DNA sensors, surface CD16 expression, and inflammasome pathway activation.
Higher proportions of intermediate monocytes (IMs) were identified in active AOSD patients. IMs displayed higher expression of CD80, CD86, HLA-DR, and CD163 than CMs and NCMs. CD163 upregulation was noted on AOSD IMs, accompanied by increased phagocytic activity and elevated cytokine/chemokine production, including IL-1β, IL-6, CCL8, and CXCL10. The frequencies of IMs were correlated with disease activity and higher in AOSD patients with MAS (AOSD-MAS). CCL8 and CXCL10 were highly expressed in RNA sequencing of monocytes from AOSD-MAS patients and plasma CXCL10 level could serve as a potential biomarker for AOSD-MAS. Moreover, DNA-sensing pathway was activated in monocytes from AOSD-MAS patients. Stimulation with NETs derived from AOSD induced DNA sensor expression, the expansion of IMs, and inflammasome pathway activation. These effects can be abrogated by DNase I treatment.
Our results demonstrated that the proportions of IMs were elevated in AOSD and associated with MAS. The DNA component in NETs from AOSD plays an important role in the formation of IMs, shedding new light for the therapeutic target. |
|---|---|
| AbstractList | Background Adult-onset Still's disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high risk for macrophage activation syndrome (MAS). MAS development is associated with monocyte/macrophage activation and cytokine storm. Monocytes consist of three different subsets, classical monocytes (CMs, CD14.sup.brightCD16 -), intermediate monocytes (IMs, CD14.sup.brightCD16 +), and non-classical monocytes (NCMs, CD14.sup.dimCD16 +), each has distinct roles in inflammatory regulation. However, the frequencies and regulatory mechanism of monocyte subsets in AOSD patients have not been identified. Methods We performed flow cytometry, RNA sequencing, phagocytosis analysis, and enzyme-linked immunosorbent assay to evaluate monocyte subsets, cell functions, and potential biomarkers. The effect of neutrophil extracellular traps (NETs) on monocytes was determined by evaluating mRNA levels of DNA sensors, surface CD16 expression, and inflammasome pathway activation. Results Higher proportions of intermediate monocytes (IMs) were identified in active AOSD patients. IMs displayed higher expression of CD80, CD86, HLA-DR, and CD163 than CMs and NCMs. CD163 upregulation was noted on AOSD IMs, accompanied by increased phagocytic activity and elevated cytokine/chemokine production, including IL-1[beta], IL-6, CCL8, and CXCL10. The frequencies of IMs were correlated with disease activity and higher in AOSD patients with MAS (AOSD-MAS). CCL8 and CXCL10 were highly expressed in RNA sequencing of monocytes from AOSD-MAS patients and plasma CXCL10 level could serve as a potential biomarker for AOSD-MAS. Moreover, DNA-sensing pathway was activated in monocytes from AOSD-MAS patients. Stimulation with NETs derived from AOSD induced DNA sensor expression, the expansion of IMs, and inflammasome pathway activation. These effects can be abrogated by DNase I treatment. Conclusions Our results demonstrated that the proportions of IMs were elevated in AOSD and associated with MAS. The DNA component in NETs from AOSD plays an important role in the formation of IMs, shedding new light for the therapeutic target. Keywords: Adult-onset Still's disease, Monocyte subset, CXCL10, Neutrophil extracellular traps, DNA sensing Adult-onset Still's disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high risk for macrophage activation syndrome (MAS). MAS development is associated with monocyte/macrophage activation and cytokine storm. Monocytes consist of three different subsets, classical monocytes (CMs, CD14 CD16 -), intermediate monocytes (IMs, CD14 CD16 +), and non-classical monocytes (NCMs, CD14 CD16 +), each has distinct roles in inflammatory regulation. However, the frequencies and regulatory mechanism of monocyte subsets in AOSD patients have not been identified. We performed flow cytometry, RNA sequencing, phagocytosis analysis, and enzyme-linked immunosorbent assay to evaluate monocyte subsets, cell functions, and potential biomarkers. The effect of neutrophil extracellular traps (NETs) on monocytes was determined by evaluating mRNA levels of DNA sensors, surface CD16 expression, and inflammasome pathway activation. Higher proportions of intermediate monocytes (IMs) were identified in active AOSD patients. IMs displayed higher expression of CD80, CD86, HLA-DR, and CD163 than CMs and NCMs. CD163 upregulation was noted on AOSD IMs, accompanied by increased phagocytic activity and elevated cytokine/chemokine production, including IL-1β, IL-6, CCL8, and CXCL10. The frequencies of IMs were correlated with disease activity and higher in AOSD patients with MAS (AOSD-MAS). CCL8 and CXCL10 were highly expressed in RNA sequencing of monocytes from AOSD-MAS patients and plasma CXCL10 level could serve as a potential biomarker for AOSD-MAS. Moreover, DNA-sensing pathway was activated in monocytes from AOSD-MAS patients. Stimulation with NETs derived from AOSD induced DNA sensor expression, the expansion of IMs, and inflammasome pathway activation. These effects can be abrogated by DNase I treatment. Our results demonstrated that the proportions of IMs were elevated in AOSD and associated with MAS. The DNA component in NETs from AOSD plays an important role in the formation of IMs, shedding new light for the therapeutic target. Adult-onset Still's disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high risk for macrophage activation syndrome (MAS). MAS development is associated with monocyte/macrophage activation and cytokine storm. Monocytes consist of three different subsets, classical monocytes (CMs, CD14.sup.brightCD16 -), intermediate monocytes (IMs, CD14.sup.brightCD16 +), and non-classical monocytes (NCMs, CD14.sup.dimCD16 +), each has distinct roles in inflammatory regulation. However, the frequencies and regulatory mechanism of monocyte subsets in AOSD patients have not been identified. We performed flow cytometry, RNA sequencing, phagocytosis analysis, and enzyme-linked immunosorbent assay to evaluate monocyte subsets, cell functions, and potential biomarkers. The effect of neutrophil extracellular traps (NETs) on monocytes was determined by evaluating mRNA levels of DNA sensors, surface CD16 expression, and inflammasome pathway activation. Higher proportions of intermediate monocytes (IMs) were identified in active AOSD patients. IMs displayed higher expression of CD80, CD86, HLA-DR, and CD163 than CMs and NCMs. CD163 upregulation was noted on AOSD IMs, accompanied by increased phagocytic activity and elevated cytokine/chemokine production, including IL-1[beta], IL-6, CCL8, and CXCL10. The frequencies of IMs were correlated with disease activity and higher in AOSD patients with MAS (AOSD-MAS). CCL8 and CXCL10 were highly expressed in RNA sequencing of monocytes from AOSD-MAS patients and plasma CXCL10 level could serve as a potential biomarker for AOSD-MAS. Moreover, DNA-sensing pathway was activated in monocytes from AOSD-MAS patients. Stimulation with NETs derived from AOSD induced DNA sensor expression, the expansion of IMs, and inflammasome pathway activation. These effects can be abrogated by DNase I treatment. Our results demonstrated that the proportions of IMs were elevated in AOSD and associated with MAS. The DNA component in NETs from AOSD plays an important role in the formation of IMs, shedding new light for the therapeutic target. Adult-onset Still's disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high risk for macrophage activation syndrome (MAS). MAS development is associated with monocyte/macrophage activation and cytokine storm. Monocytes consist of three different subsets, classical monocytes (CMs, CD14brightCD16 -), intermediate monocytes (IMs, CD14brightCD16 +), and non-classical monocytes (NCMs, CD14dimCD16 +), each has distinct roles in inflammatory regulation. However, the frequencies and regulatory mechanism of monocyte subsets in AOSD patients have not been identified.BACKGROUNDAdult-onset Still's disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high risk for macrophage activation syndrome (MAS). MAS development is associated with monocyte/macrophage activation and cytokine storm. Monocytes consist of three different subsets, classical monocytes (CMs, CD14brightCD16 -), intermediate monocytes (IMs, CD14brightCD16 +), and non-classical monocytes (NCMs, CD14dimCD16 +), each has distinct roles in inflammatory regulation. However, the frequencies and regulatory mechanism of monocyte subsets in AOSD patients have not been identified.We performed flow cytometry, RNA sequencing, phagocytosis analysis, and enzyme-linked immunosorbent assay to evaluate monocyte subsets, cell functions, and potential biomarkers. The effect of neutrophil extracellular traps (NETs) on monocytes was determined by evaluating mRNA levels of DNA sensors, surface CD16 expression, and inflammasome pathway activation.METHODSWe performed flow cytometry, RNA sequencing, phagocytosis analysis, and enzyme-linked immunosorbent assay to evaluate monocyte subsets, cell functions, and potential biomarkers. The effect of neutrophil extracellular traps (NETs) on monocytes was determined by evaluating mRNA levels of DNA sensors, surface CD16 expression, and inflammasome pathway activation.Higher proportions of intermediate monocytes (IMs) were identified in active AOSD patients. IMs displayed higher expression of CD80, CD86, HLA-DR, and CD163 than CMs and NCMs. CD163 upregulation was noted on AOSD IMs, accompanied by increased phagocytic activity and elevated cytokine/chemokine production, including IL-1β, IL-6, CCL8, and CXCL10. The frequencies of IMs were correlated with disease activity and higher in AOSD patients with MAS (AOSD-MAS). CCL8 and CXCL10 were highly expressed in RNA sequencing of monocytes from AOSD-MAS patients and plasma CXCL10 level could serve as a potential biomarker for AOSD-MAS. Moreover, DNA-sensing pathway was activated in monocytes from AOSD-MAS patients. Stimulation with NETs derived from AOSD induced DNA sensor expression, the expansion of IMs, and inflammasome pathway activation. These effects can be abrogated by DNase I treatment.RESULTSHigher proportions of intermediate monocytes (IMs) were identified in active AOSD patients. IMs displayed higher expression of CD80, CD86, HLA-DR, and CD163 than CMs and NCMs. CD163 upregulation was noted on AOSD IMs, accompanied by increased phagocytic activity and elevated cytokine/chemokine production, including IL-1β, IL-6, CCL8, and CXCL10. The frequencies of IMs were correlated with disease activity and higher in AOSD patients with MAS (AOSD-MAS). CCL8 and CXCL10 were highly expressed in RNA sequencing of monocytes from AOSD-MAS patients and plasma CXCL10 level could serve as a potential biomarker for AOSD-MAS. Moreover, DNA-sensing pathway was activated in monocytes from AOSD-MAS patients. Stimulation with NETs derived from AOSD induced DNA sensor expression, the expansion of IMs, and inflammasome pathway activation. These effects can be abrogated by DNase I treatment.Our results demonstrated that the proportions of IMs were elevated in AOSD and associated with MAS. The DNA component in NETs from AOSD plays an important role in the formation of IMs, shedding new light for the therapeutic target.CONCLUSIONSOur results demonstrated that the proportions of IMs were elevated in AOSD and associated with MAS. The DNA component in NETs from AOSD plays an important role in the formation of IMs, shedding new light for the therapeutic target. BackgroundAdult-onset Still’s disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high risk for macrophage activation syndrome (MAS). MAS development is associated with monocyte/macrophage activation and cytokine storm. Monocytes consist of three different subsets, classical monocytes (CMs, CD14brightCD16 −), intermediate monocytes (IMs, CD14brightCD16 +), and non-classical monocytes (NCMs, CD14dimCD16 +), each has distinct roles in inflammatory regulation. However, the frequencies and regulatory mechanism of monocyte subsets in AOSD patients have not been identified.MethodsWe performed flow cytometry, RNA sequencing, phagocytosis analysis, and enzyme-linked immunosorbent assay to evaluate monocyte subsets, cell functions, and potential biomarkers. The effect of neutrophil extracellular traps (NETs) on monocytes was determined by evaluating mRNA levels of DNA sensors, surface CD16 expression, and inflammasome pathway activation.ResultsHigher proportions of intermediate monocytes (IMs) were identified in active AOSD patients. IMs displayed higher expression of CD80, CD86, HLA-DR, and CD163 than CMs and NCMs. CD163 upregulation was noted on AOSD IMs, accompanied by increased phagocytic activity and elevated cytokine/chemokine production, including IL-1β, IL-6, CCL8, and CXCL10. The frequencies of IMs were correlated with disease activity and higher in AOSD patients with MAS (AOSD-MAS). CCL8 and CXCL10 were highly expressed in RNA sequencing of monocytes from AOSD-MAS patients and plasma CXCL10 level could serve as a potential biomarker for AOSD-MAS. Moreover, DNA-sensing pathway was activated in monocytes from AOSD-MAS patients. Stimulation with NETs derived from AOSD induced DNA sensor expression, the expansion of IMs, and inflammasome pathway activation. These effects can be abrogated by DNase I treatment.ConclusionsOur results demonstrated that the proportions of IMs were elevated in AOSD and associated with MAS. The DNA component in NETs from AOSD plays an important role in the formation of IMs, shedding new light for the therapeutic target. Abstract Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high risk for macrophage activation syndrome (MAS). MAS development is associated with monocyte/macrophage activation and cytokine storm. Monocytes consist of three different subsets, classical monocytes (CMs, CD14brightCD16 −), intermediate monocytes (IMs, CD14brightCD16 +), and non-classical monocytes (NCMs, CD14dimCD16 +), each has distinct roles in inflammatory regulation. However, the frequencies and regulatory mechanism of monocyte subsets in AOSD patients have not been identified. Methods We performed flow cytometry, RNA sequencing, phagocytosis analysis, and enzyme-linked immunosorbent assay to evaluate monocyte subsets, cell functions, and potential biomarkers. The effect of neutrophil extracellular traps (NETs) on monocytes was determined by evaluating mRNA levels of DNA sensors, surface CD16 expression, and inflammasome pathway activation. Results Higher proportions of intermediate monocytes (IMs) were identified in active AOSD patients. IMs displayed higher expression of CD80, CD86, HLA-DR, and CD163 than CMs and NCMs. CD163 upregulation was noted on AOSD IMs, accompanied by increased phagocytic activity and elevated cytokine/chemokine production, including IL-1β, IL-6, CCL8, and CXCL10. The frequencies of IMs were correlated with disease activity and higher in AOSD patients with MAS (AOSD-MAS). CCL8 and CXCL10 were highly expressed in RNA sequencing of monocytes from AOSD-MAS patients and plasma CXCL10 level could serve as a potential biomarker for AOSD-MAS. Moreover, DNA-sensing pathway was activated in monocytes from AOSD-MAS patients. Stimulation with NETs derived from AOSD induced DNA sensor expression, the expansion of IMs, and inflammasome pathway activation. These effects can be abrogated by DNase I treatment. Conclusions Our results demonstrated that the proportions of IMs were elevated in AOSD and associated with MAS. The DNA component in NETs from AOSD plays an important role in the formation of IMs, shedding new light for the therapeutic target. |
| ArticleNumber | 507 |
| Audience | Academic |
| Author | Sun, Yue Meng, Jianfen Xiao, Yu Chi, Huihui Shi, Hui Chen, Xia Liu, Honglei Cheng, Xiaobing Ye, Junna Su, Yutong Zhou, Zhuochao Liu, Tingting Jia, Jinchao Wang, Mengyan Yang, Chengde Zhu, Dehao Yi, Da Ma, Yuning Wang, Fan Chen, Longfang Teng, Jialin Hu, Qiongyi |
| Author_xml | – sequence: 1 givenname: Jinchao surname: Jia fullname: Jia, Jinchao – sequence: 2 givenname: Mengyan surname: Wang fullname: Wang, Mengyan – sequence: 3 givenname: Yuning surname: Ma fullname: Ma, Yuning – sequence: 4 givenname: Jianfen surname: Meng fullname: Meng, Jianfen – sequence: 5 givenname: Dehao surname: Zhu fullname: Zhu, Dehao – sequence: 6 givenname: Xia surname: Chen fullname: Chen, Xia – sequence: 7 givenname: Hui surname: Shi fullname: Shi, Hui – sequence: 8 givenname: Yue surname: Sun fullname: Sun, Yue – sequence: 9 givenname: Honglei surname: Liu fullname: Liu, Honglei – sequence: 10 givenname: Xiaobing surname: Cheng fullname: Cheng, Xiaobing – sequence: 11 givenname: Yutong surname: Su fullname: Su, Yutong – sequence: 12 givenname: Junna surname: Ye fullname: Ye, Junna – sequence: 13 givenname: Huihui surname: Chi fullname: Chi, Huihui – sequence: 14 givenname: Tingting surname: Liu fullname: Liu, Tingting – sequence: 15 givenname: Zhuochao surname: Zhou fullname: Zhou, Zhuochao – sequence: 16 givenname: Fan surname: Wang fullname: Wang, Fan – sequence: 17 givenname: Longfang surname: Chen fullname: Chen, Longfang – sequence: 18 givenname: Da surname: Yi fullname: Yi, Da – sequence: 19 givenname: Yu surname: Xiao fullname: Xiao, Yu – sequence: 20 givenname: Chengde surname: Yang fullname: Yang, Chengde – sequence: 21 givenname: Jialin surname: Teng fullname: Teng, Jialin – sequence: 22 givenname: Qiongyi surname: Hu fullname: Hu, Qiongyi |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38124139$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstu1DAYhSNURC_wAixQJCTEJiW-JI5XqKq4VKpgAaytv_afGVeOPcROxexY8BK8Hk-CM9PCTIWQF7bs7xzZx-e4OPDBY1E8JfUpIV37KhIqSVvVlFU1o4xU8kFxRAQnlahJc7CzPiyOY7yua9oIwR8Vh6wjlBMmj4ofH3BKY1gtrSvxWxpBo3OTg7HM61VlvZk0mtL6hOOAxkLCcgg-6HXCmBm7WOBYDqBnD1hgCTrZG0g2-DKuvRnDgFldgplcqoKPmMpPyTr36_vPWBobESI-Lh724CI-uZ1Pii9v33w-f19dfnx3cX52WelGNqnSGqmg2IoOTC1YDY3QjSYN07yXALrvrvoeAIzpakNRtkz0fUd7YggaIxk7KS62vibAtVqNdoBxrQJYtdkI40LBmKx2qNpaGlY3KHnLuTYUGJFCEG6YBNEZkr1eb71W01UORqPPgbk90_0Tb5dqEW4UyVfnRHbZ4eWtwxi-ThiTGmyc4wePYYqKypo3omG0zejze-h1mEafs8oU4bTjXLC_1ALyC6zvw_yfs6k6E6LtOtK2NFOn_6DyMDhYnRvW27y_J3ixI1giuLSMwU3zH8d98NluJH-yuGtbBrotkNsS44i90jZtupKvYF2ORs3FVttiq1xstSm2mqX0nvTO_T-i32Qj_X0 |
| CitedBy_id | crossref_primary_10_3390_cimb46020075 crossref_primary_10_1093_jleuko_qiae138 crossref_primary_10_3390_biomedicines13010065 crossref_primary_10_1016_S2665_9913_24_00225_X crossref_primary_10_1186_s12916_024_03702_7 crossref_primary_10_1080_25785826_2024_2411094 crossref_primary_10_3389_fmed_2025_1498928 crossref_primary_10_1097_BOR_0000000000001054 crossref_primary_10_1093_mr_roaf009 |
| Cites_doi | 10.1186/s13075-018-1800-z 10.1016/j.immuni.2018.10.005 10.1186/s13075-020-02234-8 10.1007/s12026-012-8297-3 10.1016/j.cytogfr.2014.07.019 10.1002/art.38690 10.3389/fimmu.2019.00898 10.3389/fimmu.2020.554725 10.1016/j.jaut.2022.102793 10.1038/s41590-023-01468-3 10.1038/s41584-018-0081-x 10.3389/fimmu.2015.00423 10.1182/blood.2019000761 10.1093/nsr/nwaa041 10.1136/jitc-2021-003539 10.1182/blood-2013-02-484188 10.1111/ijlh.13941 10.1016/j.arr.2016.04.002 10.1182/blood-2004-08-2997 10.1016/j.clim.2022.109160 10.1097/RHU.0000000000000931 10.1186/s13075-015-0773-4 10.1038/nrrheum.2015.179 10.1093/cvr/cvy112 10.15252/emmm.202013001 10.3389/fimmu.2020.01070 10.1016/j.berh.2020.101515 10.1038/nm.4027 10.3389/fimmu.2020.563335 10.1097/CM9.0000000000000538 10.1016/j.jaci.2022.06.017 10.3390/biom9080365 10.3389/fimmu.2017.00081 10.1093/rheumatology/keaa814 10.3899/jrheum.100247 10.1007/s12026-014-8561-9 10.1186/s13075-016-1216-6 10.1111/cei.12738 10.3389/fimmu.2016.00512 10.1038/s41467-022-34560-7 10.1016/j.autrev.2008.12.002 10.3389/fimmu.2018.01726 10.1016/j.jaut.2018.07.018 10.1038/s41584-018-0039-z 10.1038/s41581-019-0163-2 10.1136/annrheumdis-2015-208982 10.1182/blood-2011-01-326827 10.1007/s10067-020-04949-0 10.1136/annrheumdis-2015-209020 |
| ContentType | Journal Article |
| Copyright | 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2023 |
| Copyright_xml | – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2023 |
| DBID | AAYXX CITATION NPM 3V. 7QL 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1186/s12916-023-03231-9 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Proquest Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1741-7015 |
| EndPage | 15 |
| ExternalDocumentID | oai_doaj_org_article_609d305e94644cd2a3197714d39a78d1 PMC10734198 A776881662 38124139 10_1186_s12916_023_03231_9 |
| Genre | Journal Article |
| GeographicLocations | China United States--US Japan |
| GeographicLocations_xml | – name: China – name: United States--US – name: Japan |
| GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 82171769 – fundername: National Natural Science Foundation of China grantid: 82001704 – fundername: Shanghai Sailing Program grantid: 23YF1424600 – fundername: Shanghai Sailing Program grantid: 22YF1425600 – fundername: Chenguang Program of Shanghai Education Development Foundation and Shanghai Municipal Education Commission grantid: 22CGA14 – fundername: Shanghai Science and Technology Innovation Action grantid: 20Y11911500 – fundername: Shanghai Rising-Star Program grantid: RC20220021 – fundername: Shanghai Pujiang Young Rheumatologists Training program grantid: SPROG2109 – fundername: National Natural Science Foundation of China grantid: 82201969 |
| GroupedDBID | --- 0R~ 23N 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M1P M48 MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB NPM PJZUB PPXIY PMFND 3V. 7QL 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PKEHL PQEST PQUKI 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c595t-cce272e678ad0730a57c5c153c4f9aacf8bffaaadd80d2e9637ff82f1d1edd933 |
| IEDL.DBID | M48 |
| ISSN | 1741-7015 |
| IngestDate | Wed Aug 27 01:24:10 EDT 2025 Thu Aug 21 18:37:33 EDT 2025 Fri Jul 11 15:39:56 EDT 2025 Sat Jul 26 00:12:32 EDT 2025 Tue Jun 17 22:27:30 EDT 2025 Tue Jun 10 21:15:56 EDT 2025 Thu May 22 21:17:10 EDT 2025 Mon Jul 21 06:06:45 EDT 2025 Tue Jul 01 02:51:37 EDT 2025 Thu Apr 24 22:53:29 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | CXCL10 Monocyte subset Adult-onset Still’s disease DNA sensing Neutrophil extracellular traps |
| Language | English |
| License | 2023. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c595t-cce272e678ad0730a57c5c153c4f9aacf8bffaaadd80d2e9637ff82f1d1edd933 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12916-023-03231-9 |
| PMID | 38124139 |
| PQID | 2914284473 |
| PQPubID | 42775 |
| PageCount | 15 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_609d305e94644cd2a3197714d39a78d1 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10734198 proquest_miscellaneous_2904575326 proquest_journals_2914284473 gale_infotracmisc_A776881662 gale_infotracacademiconefile_A776881662 gale_healthsolutions_A776881662 pubmed_primary_38124139 crossref_citationtrail_10_1186_s12916_023_03231_9 crossref_primary_10_1186_s12916_023_03231_9 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-12-20 |
| PublicationDateYYYYMMDD | 2023-12-20 |
| PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-20 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC medicine |
| PublicationTitleAlternate | BMC Med |
| PublicationYear | 2023 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | 3231_CR24 MY Wang (3231_CR1) 2019; 132 V Delgado-Rizo (3231_CR43) 2017; 8 Q Yin (3231_CR30) 2022; 245 KL Wong (3231_CR12) 2012; 53 L Ziegler-Heitbrock (3231_CR10) 2015; 6 H Zhu (3231_CR14) 2016; 7 AA Grom (3231_CR6) 2016; 12 Y Jamilloux (3231_CR45) 2015; 61 F Apel (3231_CR41) 2018; 14 D Choubey (3231_CR48) 2016; 28 H Nagai (3231_CR25) 2021; 60 G Griffin (3231_CR3) 2020; 34 C Bracaglia (3231_CR36) 2017; 76 R Loperena (3231_CR39) 2018; 114 3231_CR19 Y Zhou (3231_CR15) 2020; 7 M Tsukamoto (3231_CR13) 2017; 19 T Shimizu (3231_CR26) 2020; 26 C Lood (3231_CR49) 2016; 22 M Guilliams (3231_CR7) 2018; 49 P Sampath (3231_CR11) 2018; 9 J Jia (3231_CR20) 2022; 13 A Ravelli (3231_CR22) 2016; 75 EY Lee (3231_CR35) 2009; 8 R Wang (3231_CR4) 2020; 39 JH Han (3231_CR37) 2015; 17 J Jia (3231_CR40) 2020; 11 P Ruscitti (3231_CR27) 2016; 183 S Albeituni (3231_CR31) 2019; 134 AD Billiau (3231_CR9) 2005; 105 C Schmidl (3231_CR28) 2014; 123 AM Zawada (3231_CR17) 2011; 118 S Cormican (3231_CR29) 2020; 11 E Feist (3231_CR2) 2018; 14 M Rau (3231_CR21) 2010; 37 Y Tang (3231_CR8) 2022; 150 3231_CR42 C Daniel (3231_CR44) 2019; 15 3231_CR32 3231_CR38 L Fardet (3231_CR23) 2014; 66 G Tumurkhuu (3231_CR46) 2020; 11 M Cusinato (3231_CR16) 2022; 44 L Gibellini (3231_CR18) 2020; 12 R Giacomelli (3231_CR5) 2018; 93 S Smith (3231_CR47) 2014; 25 Y Ma (3231_CR34) 2022; 127 J Jia (3231_CR33) 2019; 10 |
| References_xml | – ident: 3231_CR19 doi: 10.1186/s13075-018-1800-z – volume: 49 start-page: 595 issue: 4 year: 2018 ident: 3231_CR7 publication-title: Immunity doi: 10.1016/j.immuni.2018.10.005 – ident: 3231_CR32 doi: 10.1186/s13075-020-02234-8 – volume: 53 start-page: 41 issue: 1–3 year: 2012 ident: 3231_CR12 publication-title: Immunol Res doi: 10.1007/s12026-012-8297-3 – volume: 25 start-page: 745 issue: 6 year: 2014 ident: 3231_CR47 publication-title: Cytokine Growth Factor Rev doi: 10.1016/j.cytogfr.2014.07.019 – volume: 66 start-page: 2613 issue: 9 year: 2014 ident: 3231_CR23 publication-title: Arthritis Rheumatol doi: 10.1002/art.38690 – volume: 10 start-page: 898 year: 2019 ident: 3231_CR33 publication-title: Front Immunol doi: 10.3389/fimmu.2019.00898 – volume: 11 start-page: 554725 year: 2020 ident: 3231_CR46 publication-title: Front Immunol doi: 10.3389/fimmu.2020.554725 – volume: 127 start-page: 102793 year: 2022 ident: 3231_CR34 publication-title: J Autoimmun doi: 10.1016/j.jaut.2022.102793 – ident: 3231_CR24 doi: 10.1038/s41590-023-01468-3 – volume: 14 start-page: 603 issue: 10 year: 2018 ident: 3231_CR2 publication-title: Nat Rev Rheumatol doi: 10.1038/s41584-018-0081-x – volume: 6 start-page: 423 year: 2015 ident: 3231_CR10 publication-title: Front Immunol doi: 10.3389/fimmu.2015.00423 – volume: 134 start-page: 147 issue: 2 year: 2019 ident: 3231_CR31 publication-title: Blood doi: 10.1182/blood.2019000761 – volume: 7 start-page: 998 issue: 6 year: 2020 ident: 3231_CR15 publication-title: Natl Sci Rev doi: 10.1093/nsr/nwaa041 – ident: 3231_CR38 doi: 10.1136/jitc-2021-003539 – volume: 123 start-page: e90 issue: 17 year: 2014 ident: 3231_CR28 publication-title: Blood doi: 10.1182/blood-2013-02-484188 – volume: 44 start-page: 1029 issue: 6 year: 2022 ident: 3231_CR16 publication-title: Int J Lab Hematol doi: 10.1111/ijlh.13941 – volume: 28 start-page: 27 year: 2016 ident: 3231_CR48 publication-title: Ageing Res Rev doi: 10.1016/j.arr.2016.04.002 – volume: 105 start-page: 1648 issue: 4 year: 2005 ident: 3231_CR9 publication-title: Blood doi: 10.1182/blood-2004-08-2997 – volume: 245 start-page: 109160 year: 2022 ident: 3231_CR30 publication-title: Clin Immunol doi: 10.1016/j.clim.2022.109160 – volume: 26 start-page: 67 issue: 2 year: 2020 ident: 3231_CR26 publication-title: J Clin Rheumatol doi: 10.1097/RHU.0000000000000931 – volume: 17 start-page: 260 issue: 1 year: 2015 ident: 3231_CR37 publication-title: Arthritis Res Ther doi: 10.1186/s13075-015-0773-4 – volume: 12 start-page: 259 issue: 5 year: 2016 ident: 3231_CR6 publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2015.179 – volume: 114 start-page: 1547 issue: 11 year: 2018 ident: 3231_CR39 publication-title: Cardiovasc Res doi: 10.1093/cvr/cvy112 – volume: 12 start-page: e13001 issue: 12 year: 2020 ident: 3231_CR18 publication-title: EMBO Mol Med doi: 10.15252/emmm.202013001 – volume: 11 start-page: 1070 year: 2020 ident: 3231_CR29 publication-title: Front Immunol doi: 10.3389/fimmu.2020.01070 – volume: 34 start-page: 101515 issue: 4 year: 2020 ident: 3231_CR3 publication-title: Best Pract Res Clin Rheumatol doi: 10.1016/j.berh.2020.101515 – volume: 22 start-page: 146 issue: 2 year: 2016 ident: 3231_CR49 publication-title: Nat Med doi: 10.1038/nm.4027 – volume: 11 start-page: 563335 year: 2020 ident: 3231_CR40 publication-title: Front Immunol doi: 10.3389/fimmu.2020.563335 – volume: 132 start-page: 2856 issue: 23 year: 2019 ident: 3231_CR1 publication-title: Chin Med J (Engl) doi: 10.1097/CM9.0000000000000538 – volume: 150 start-page: 1154 issue: 5 year: 2022 ident: 3231_CR8 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2022.06.017 – ident: 3231_CR42 doi: 10.3390/biom9080365 – volume: 8 start-page: 81 year: 2017 ident: 3231_CR43 publication-title: Front Immunol doi: 10.3389/fimmu.2017.00081 – volume: 60 start-page: 3888 issue: 8 year: 2021 ident: 3231_CR25 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keaa814 – volume: 37 start-page: 2369 issue: 11 year: 2010 ident: 3231_CR21 publication-title: J Rheumatol doi: 10.3899/jrheum.100247 – volume: 61 start-page: 53 issue: 1–2 year: 2015 ident: 3231_CR45 publication-title: Immunol Res doi: 10.1007/s12026-014-8561-9 – volume: 19 start-page: 28 issue: 1 year: 2017 ident: 3231_CR13 publication-title: Arthritis Res Ther doi: 10.1186/s13075-016-1216-6 – volume: 183 start-page: 397 issue: 3 year: 2016 ident: 3231_CR27 publication-title: Clin Exp Immunol doi: 10.1111/cei.12738 – volume: 7 start-page: 512 year: 2016 ident: 3231_CR14 publication-title: Front Immunol doi: 10.3389/fimmu.2016.00512 – volume: 13 start-page: 6804 issue: 1 year: 2022 ident: 3231_CR20 publication-title: Nat Commun doi: 10.1038/s41467-022-34560-7 – volume: 8 start-page: 379 issue: 5 year: 2009 ident: 3231_CR35 publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2008.12.002 – volume: 9 start-page: 1726 year: 2018 ident: 3231_CR11 publication-title: Front Immunol doi: 10.3389/fimmu.2018.01726 – volume: 93 start-page: 24 year: 2018 ident: 3231_CR5 publication-title: J Autoimmun doi: 10.1016/j.jaut.2018.07.018 – volume: 14 start-page: 467 issue: 8 year: 2018 ident: 3231_CR41 publication-title: Nat Rev Rheumatol doi: 10.1038/s41584-018-0039-z – volume: 15 start-page: 559 issue: 9 year: 2019 ident: 3231_CR44 publication-title: Nat Rev Nephrol doi: 10.1038/s41581-019-0163-2 – volume: 75 start-page: 481 issue: 3 year: 2016 ident: 3231_CR22 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2015-208982 – volume: 118 start-page: e50 issue: 12 year: 2011 ident: 3231_CR17 publication-title: Blood doi: 10.1182/blood-2011-01-326827 – volume: 39 start-page: 2379 issue: 8 year: 2020 ident: 3231_CR4 publication-title: Clin Rheumatol doi: 10.1007/s10067-020-04949-0 – volume: 76 start-page: 166 issue: 1 year: 2017 ident: 3231_CR36 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2015-209020 |
| SSID | ssj0025774 |
| Score | 2.4557362 |
| Snippet | Adult-onset Still's disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high risk for macrophage... Background Adult-onset Still's disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high risk for... BackgroundAdult-onset Still’s disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high risk for... Abstract Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disease characterized by innate immune system activation, with a high... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 507 |
| SubjectTerms | Adult-onset Still’s disease Analysis Antibodies Arthritis Biomarkers CD16 antigen CD163 antigen CD80 antigen CD86 antigen Cell activation Chemokines Coronaviruses COVID-19 CXCL10 CXCL10 protein Cytokine storm Cytokines Deoxyribonuclease Deoxyribonucleic acid Disease DNA DNA sensing Enzyme-linked immunosorbent assay Fever Flow cytometry Gene expression Gene sequencing Health aspects Immune system Inflammasomes Inflammation Inflammatory diseases Innate immunity Leukocytes (neutrophilic) Lymphocytes Macrophages Measurement Monocyte subset Monocytes mRNA Neutrophil extracellular traps Neutrophils Pathogenesis Phagocytes Phagocytosis Regulatory mechanisms (biology) Ribonucleic acid RNA RNA sequencing Therapeutic targets Tumor necrosis factor-TNF |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9QwFA-yB_EifltdNYLgQcI2adMkx1VcFmH3ogt7C5kk3RkYO0Onc_DmwX_Cf8-_xPfSD6YIevFWmhdo8n55H83LL4S8WbhCGl5yVuVBMjB4nDmAAfO6zjn0iT3jzcVldX5VfrqW1wdXfWFNWE8P3E_cSZWbAJiMpgTP7YNwgBmleBkK45QOKfEBnzcmU0OqJSGqGY_I6OpkB16NY7FtwfICIhpmZm4osfX_aZMPnNK8YPLAA53dI3eH0JGe9p98n9yKzQNy-2LYHH9IflzGfddutsvVmoLJbR3-lMcqUwrPWwbJN6gxUCSIaNOBkS5SAOHGf4NwE2RWNzexpV8dXuq1BDND8cxD_8eWjsQG0Jsmyg6GVdgd_dyt1utf33_u6LDT84hcnX388uGcDZcsMC-N7Jj3USgRwWe5gMvdSeWlBzvoy9o452u9qGvnwAzqPIgI61XVtRY1DzyGYIriMTlqNk18SqiOkMspBzm1cmAKcldKob3UIdQmSC0ywsc5t35gIMeLMNY2ZSK6sr2eLOjJJj1Zk5F3U59tz7_xV-n3qMpJErmz0wtAlB0QZf-FqIy8QiDY_iDqZAHsqYLUDLdZYSBvkwTaANSmG44ywDQgm9ZM8ngmCWvXz5tHsNnBduwsDApywrJURUZeT83YE-vhmrjZowyE4pBpiiojT3psToMuMGaDwD4jeoba2azMW5rVMjGLc0BAyY1-9j_m8Tm5I3DFcQGm-Jgcde0-voAIrlu8TIv1Nw2YQ_8 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NjtMwELZgkRAXxD-BBYyExAFZGydxbJ_QglitkHYvsFJvlms7baVuUtL0wI0DL8Hr8STMJG52I6S9VfW4qj0zn2fs8WdC3s1tLjQvOCtTLxgAHmcWzIA5VaUc-oSB8ebsvDy9KL7OxCxuuG1jWeUeE3ug9o3DPfIj-BWIlItC5h83Pxi-GoWnq_EJjdvkDlKXYUmXnF0lXAJim_1FGVUebWFt41hym7M0h7iG6cli1HP2_4_M15amadnktXXo5AG5HwNIejxo_CG5FepH5O5ZPCJ_TH6fh13XNpvlak0BeFuLW_NYa0rh84ZBCg7K9BRpItr-2kgXKIytcT8h6ASZ1WIRWnpp8WmvJYANxZsPw74t3dMbQG_aE3cwrMXu6LdutV7__fVnS-N5zxNycfLl--dTFp9aYE5o0THnQiazACuX9ej0VkgnHKChKyptravUvKqsBTBUqc8CeK2sKpVV3PPgvc7zp-SgburwnFAVIKOTFjJraQEQUluITDmhvK-0FypLCN_PuXGRhxyfw1ibPh9RpRn0ZEBPpteT0Qn5MPbZDCwcN0p_QlWOksig3X_RtAsTHdKUqfaAdUEXEBE6n1nAIil54XNtpfI8IW_QEMxwHXXEAXMsIUHDw1YYyPteApEAtWnjhQaYBuTUmkgeTiTBg920eW9sJiLI1lzZe0Lejs3YE6vi6tDsUAYCcsg3szIhzwbbHAedY-QG4X1C1MRqJ7MybalXy55fnIMFFFyrFzf_r5fkXoa-xDOA2kNy0LW78AoitG7-unfDf9ZkPN4 priority: 102 providerName: ProQuest |
| Title | Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still’s disease |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38124139 https://www.proquest.com/docview/2914284473 https://www.proquest.com/docview/2904575326 https://pubmed.ncbi.nlm.nih.gov/PMC10734198 https://doaj.org/article/609d305e94644cd2a3197714d39a78d1 |
| Volume | 21 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LixNBEG72ActexLezu8YWBA8yOj2v7jmIbGSXRUiQ1UDw0nS6e5JATOJkAu7Ng3_Cv-cvsarnQQYXD17CkK46dFfVV1X9qCLkxURFScZi5qeBSXwAPOYrUANfizxgwGOrijeDYXo1ij-Mk_Eeadod1Qu4uTW1w35So2Lx-vu3m3dg8G-dwYv0zQZ8FsOrtJEfRBCv-Nk-OQTPxNFQB3F7qgDayePm4cytfMfkKEKPx7B3-I6fcuX8_wbtHa_VvVG546Iu75I7dWxJzytluEf27PI-ORrUp-cPyM-h3ZbFaj2bLyhgcqFw1x6voVL4XvuQnYOcDcUKEoV7UVJaClq60jcQjwLNfDq1Bf2qsOvXDHCI4qOIakuXNpUPgJu6mh4-XtMu6adyvlj8_vFrQ-ujoIdkdHnx-f2VX3dh8HWSJaWvtQ15aMGpKYN4oBKuEw1AqeM8U0rnYpLnSgFOisCEFgya57kIc2aYNSaLokfkYLla2ieECgvJHleQdHMFWBGoOAmFToQxeWYSEXqENWsudV2iHDtlLKRLVUQqK5FJEJl0IpOZR161POuqQMc_qfsoypYSi2u7P1bFVNa2KtMgMwCDNoshWNQmVABTnLPYRJniwjCPPENFkNVL1RYi5DmH3A3PYWEiLx0Fqi1KU9VvHWAZsNxWh_KsQwnGrbvDjbLJxjYkTAqSxjjmkUeet8PIiRfmlna1RRqI1SEVDVOPPK50s510o-IeER2t7axKd2Q5n7nS4ww0IGaZOPl_1lNyHKLJsRAQ-owclMXWPoXArpz0yD4f8x457F8MP1733PZIz1kw_F73v_wBcUBSBg |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELaqVAIuiDcLhRoJxAFZXXtf3gNCLbRKaRMhaKXeXMf2JpFCNmw2Qr1x4E_wJ_hR_BJm9hG6Quqttyg7jrKe8ef57HkQ8nKkgyjlIWexbyMGgMeZBjNgRmY-hzGurngzGMb90_DjWXS2QX63uTAYVtliYgXUNjd4Rr4DvwKechgmwbvFN4Zdo_B2tW2hUZvFkbv4DpRt-fbwA-j3lRAH-yfv-6zpKsBMlEYlM8aJRDgAaW3RvnWUmMjAwjdhlmptMjnKMq1h3UvfCgcGmmSZFBm33Fmb4gEoQP5mGACV6ZHNvf3hp89riheBN9Wm5sh4Zwm7Kccg34D5AXhSLO1sf1WXgP_3gkubYTdQ89LOd3CH3G5cVrpb29hdsuHm98iNQXMpf5_8HLpVWeSLyXRGAeoLjZcBGN1K4fOCAekH87EUC1MUVaJK6SjMZm4uwM0Fmel47Ar6VWMzsQnAG8Vci_qkmLYFFWA0rUqFMIz-LumXcjqb_fnxa0mbG6YH5PRa1PCQ9Ob53D0mVDrgkIkGLp9ogCBfh5GQJpLWZqmNpPAIb-dcmabyOTbgmKmKAclY1XpSoCdV6UmlHnmzHrOo635cKb2HqlxLYs3u6ou8GKsGAlTspxbQ1aUh-KDGCg3olyQ8tEGqE2m5R7bREFSdALtGHrWbACXE6114kdeVBGIPalM3KRQwDVjFqyO51ZEEzDDdx62xqQazlurfCvPIi_VjHIlxeHOXr1AGKAAwXBF75FFtm-uXDtBXBELhEdmx2s6sdJ_Mp5OqojkHCwh5Kp9c_b-2yc3-yeBYHR8Oj56SWwLXFRcA9FukVxYr9wz8w3L0vFmUlJxfNw78BTYcffk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neutrophil+extracellular+trap-induced+intermediate+monocytes+trigger+macrophage+activation+syndrome+in+adult-onset+Still%E2%80%99s+disease&rft.jtitle=BMC+medicine&rft.au=Jia%2C+Jinchao&rft.au=Wang%2C+Mengyan&rft.au=Ma%2C+Yuning&rft.au=Meng%2C+Jianfen&rft.date=2023-12-20&rft.pub=BioMed+Central&rft.eissn=1741-7015&rft.volume=21&rft_id=info:doi/10.1186%2Fs12916-023-03231-9&rft_id=info%3Apmid%2F38124139&rft.externalDocID=PMC10734198 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1741-7015&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1741-7015&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1741-7015&client=summon |